Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K ATP channels

The role of K ATP channels in the antiarrhythmic effect of Escherichia coli endotoxin-induced nitric oxide synthase (iNOS) was examined in an anesthetised rat model of myocardial ischemia and reperfusion arrhythmia by using glibenclamide (1 mg kg − 1 ), nateglinide (10 mg kg − 1 ) and repaglinide (0...

Full description

Saved in:
Bibliographic Details
Published in:Vascular pharmacology Vol. 46; no. 2; pp. 129 - 136
Main Authors: Iskit, Alper B., Erkent, Ulkem, Ertunc, Mert, Guc, M. Oguz, Ilhan, Mustafa, Onur, Rustu
Format: Journal Article
Language:English
Published: Elsevier Inc 01-02-2007
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The role of K ATP channels in the antiarrhythmic effect of Escherichia coli endotoxin-induced nitric oxide synthase (iNOS) was examined in an anesthetised rat model of myocardial ischemia and reperfusion arrhythmia by using glibenclamide (1 mg kg − 1 ), nateglinide (10 mg kg − 1 ) and repaglinide (0.5 mg kg − 1 ). Endotoxin (1 mg kg − 1 ) was administered intraperitoneally 4 h before the occlusion of the left coronary artery and glibenclamide, nateglinide or repaglinide was administered 30 min before coronary artery occlusion. We also evaluated the effects of K ATP channel blockers and nonselective K + channel blocker tetraethylammonium (TEA) on cardiac action potential configuration in the atria obtained from endotoxemic rats. The mean arterial blood pressure of rats receiving endotoxin was lower during both the occlusion and reperfusion periods. Endotoxin significantly reduced the total number of ectopic beats and the duration of ventricular tachycardia. Glibenclamide, but not nateglinide and repaglinide, prevented the hypotension and antiarrhythmic effects of endotoxin. Atria obtained from endotoxin-treated rats had prolonged action potential duration. This effect was abolished with pretreatment of iNOS inhibitors, l-canavanine and dexamethasone and perfusion of glibenclamide, but not with TEA and non-sulfonylurea drug, nateglinide. We demonstrated that glibenclamide inhibits the antiarrhythmic effect of endotoxin and this effect does not appear to involve K ATP channels.
ISSN:1537-1891
1879-3649
DOI:10.1016/j.vph.2006.08.415